Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole L Michmerhuizen

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Trends in Cancer|June 9, 2026
Condensates in fusion oncoprotein-driven leukemia: new biology and therapeutic opportunitiesNicole L Michmerhuizen, Richard W Kriwacki, Charles G Mullighan
Blood|August 9, 2020
Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignanciesNicole L Michmerhuizen, Jeffery M Klco, Charles G Mullighan
Otorhinolaryngology-Head and Neck Surgery|December 23, 2016
Differential compensation mechanisms define resistance to PI3K inhibitors in <i>PIK3CA</i> amplified HNSCCNicole L Michmerhuizen, Elizabeth Leonard, Aditi Kulkarni, et al.
Genes & Cancer|August 24, 2016
Genetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicineNicole L Michmerhuizen, Andrew C Birkeland, Carol R Bradford, et al.
The Journal of Physical Chemistry. B|January 28, 2014
An isothermal titration and differential scanning calorimetry study of the G-quadruplex DNA-insulin interactionChristine M Timmer, Nicole L Michmerhuizen, Amanda B Witte, et al.
Head & Neck|February 11, 2018
Comprehensive review of genetic factors contributing to head and neck squamous cell carcinoma development in low-risk, nontraditional patientsMorgan A Gingerich, Joshua D Smith, Nicole L Michmerhuizen, et al.
Molecular Pharmacology|March 13, 2019
Rationale for Using Irreversible Epidermal Growth Factor Receptor Inhibitors in Combination with Phosphatidylinositol 3-Kinase Inhibitors for Advanced Head and Neck Squamous Cell CarcinomaNicole L Michmerhuizen, Elizabeth Leonard, Chloe Matovina, et al.
Archives of Oral Biology|October 16, 2023
Multi-kinase compensation rescues EGFR knockout in a cell line model of head and neck squamous cell carcinomaMegan L Ludwig, Nicole L Michmerhuizen, Jiayu Wang, et al.
Journal of Neurological Surgery. Part B, Skull Base|February 14, 2022
Advancement of PI3 Kinase Inhibitor Combination Therapies for PI3K-Aberrant ChordomaMolly E Heft Neal, Nicole L Michmerhuizen, Kevin J Kovatch, et al.
Molecular Pharmaceutics|September 16, 2014
Poly(amidoamine) dendrimer-methotrexate conjugates: the mechanism of interaction with folate binding proteinMallory A van Dongen, Rahul Rattan, Justin Silpe, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Trends in Cancer|June 9, 2026
Condensates in fusion oncoprotein-driven leukemia: new biology and therapeutic opportunitiesNicole L Michmerhuizen, Richard W Kriwacki, Charles G Mullighan
Blood|August 9, 2020
Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignanciesNicole L Michmerhuizen, Jeffery M Klco, Charles G Mullighan
Otorhinolaryngology-Head and Neck Surgery|December 23, 2016
Differential compensation mechanisms define resistance to PI3K inhibitors in <i>PIK3CA</i> amplified HNSCCNicole L Michmerhuizen, Elizabeth Leonard, Aditi Kulkarni, et al.
Genes & Cancer|August 24, 2016
Genetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicineNicole L Michmerhuizen, Andrew C Birkeland, Carol R Bradford, et al.
The Journal of Physical Chemistry. B|January 28, 2014
An isothermal titration and differential scanning calorimetry study of the G-quadruplex DNA-insulin interactionChristine M Timmer, Nicole L Michmerhuizen, Amanda B Witte, et al.
Head & Neck|February 11, 2018
Comprehensive review of genetic factors contributing to head and neck squamous cell carcinoma development in low-risk, nontraditional patientsMorgan A Gingerich, Joshua D Smith, Nicole L Michmerhuizen, et al.
Molecular Pharmacology|March 13, 2019
Rationale for Using Irreversible Epidermal Growth Factor Receptor Inhibitors in Combination with Phosphatidylinositol 3-Kinase Inhibitors for Advanced Head and Neck Squamous Cell CarcinomaNicole L Michmerhuizen, Elizabeth Leonard, Chloe Matovina, et al.
Archives of Oral Biology|October 16, 2023
Multi-kinase compensation rescues EGFR knockout in a cell line model of head and neck squamous cell carcinomaMegan L Ludwig, Nicole L Michmerhuizen, Jiayu Wang, et al.
Journal of Neurological Surgery. Part B, Skull Base|February 14, 2022
Advancement of PI3 Kinase Inhibitor Combination Therapies for PI3K-Aberrant ChordomaMolly E Heft Neal, Nicole L Michmerhuizen, Kevin J Kovatch, et al.
Molecular Pharmaceutics|September 16, 2014
Poly(amidoamine) dendrimer-methotrexate conjugates: the mechanism of interaction with folate binding proteinMallory A van Dongen, Rahul Rattan, Justin Silpe, et al.
Pageof 3